CollPlant Biotechnologies Ltd. (CLGN)
CollPlant Biotechnologies Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
CollPlant Biotechnologies Ltd. (CLGN) is a Biotechnology company based in IL with a market capitalization of $4.1M. Revenue grew 360.4% year-over-year and free cash flow was negative at -$9.4M. This page tracks CLGN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
IL · 57 employees · IPO Jan 31, 2018
Valuation
Valuation & price
$0.42as of May 26, 2026· -86.8% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.67
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$4.1M
Market cap
360.4%
Revenue growth (YoY)
26.3%
Gross margin
-$9.4M
Free cash flow (USD)
-$3.1M
Net debt
Net cash position
6.5%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 29, 2026 (EPS $-0.23)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is CollPlant Biotechnologies Ltd.'s market cap?
CollPlant Biotechnologies Ltd. (CLGN) has a market capitalization of $4.1M.
What is CLGN's P/E ratio?
A meaningful P/E ratio is not available for CLGN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is CLGN's price-to-book (P/B) ratio?
CLGN trades at 0.67 times book value per share.
When did CollPlant Biotechnologies Ltd. last report earnings?
CLGN last reported earnings on May 29, 2026; the next date is not yet scheduled.
Are insiders buying CLGN stock?
SEC Form 4 filings show no open-market insider buys at CollPlant Biotechnologies Ltd. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.